Chemotherapy before surgery for older adults with pancreatic head cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at giving chemotherapy before surgery to people 70 and older who have pancreatic cancer in the head of the pancreas. The goal is to see if this approach helps shrink the tumor and improve outcomes compared to surgery alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years of age or older.
- Your cancer is in the head of the pancreas, not the body or tail.
- Your cancer has not spread to other parts of the body (it's not metastatic).
- The tumor can be removed with surgery (or may be borderline removable).
- Your overall health is good enough to receive chemotherapy and undergo surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial tests a combination of an immunotherapy drug (adebrelimab) with chemotherapy before surgery for pancreatic cancer. The goal is to see if this approach can shrink the tumor and improve outcomes for patients whose cancer can be surgically removed.
This trial tests giving chemotherapy before any surgery to people with borderline resectable or locally advanced pancreatic cancer. The goal is to shrink the tumor, which may make surgery more successful and improve outcomes.
This Phase 2 trial tests a chemotherapy plan given before surgery (called “neoadjuvant” treatment) for people with pancreatic adenocarcinoma that looks resectable or borderline resectable on scans. The goal is to see how well this adaptive chemotherapy approach works and whether it can improve outcomes before an operation.
This trial tests whether a combination of chemotherapy and radiation can help older adults (70+ years) with pancreatic cancer that hasn't spread and can't be removed surgically. The goal is to control the tumor and improve quality of life without surgery.
This trial tests a combination of three chemotherapy drugs given before surgery for pancreatic cancer that is removable or borderline removable. The goal is to shrink the tumor to make surgery more successful.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.